Literature DB >> 28638686

Rheumatoid Arthritis: Are psychological factors effective in disease flare?

Volkan Yılmaz1, Ebru Umay1, İbrahim Gündoğdu1, Zeliha Özgür Karaahmet1, Arif Erhan Öztürk1.   

Abstract

OBJECTIVE: Rheumatoid arthritis (RA) is clinically an undulant disease, and reasons for flare or remission vary. We aimed to identify factors potentially associated with disease flare and remission.
MATERIAL AND METHODS: Two hundred and seventy-four patients with RA who were admitted to our center between January 2010 and January 2016 were included. Disease activity was evaluated using disease activity score 28 (DAS 28); functional status was evaluated using the modified Health Assessment Questionnaire (m-HAQ), a questionnaire that comprises flare or remission domains such as psychological stress and mood status, physical trauma, nutrition regimen, infection, antibiotic use, and seasonal weather changes. Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI) were used to identify if patients had a mood disorder. Four subscales of Arthritis Impact Measurement Scale-2 (AIMS-2) (level of tension, mood, general perception of health, and satisfaction with health) were used to determine patient quality of life.
RESULTS: Of the 274 patients, 261 were female (95.3%) and 13 were male (4.7%); the mean age was 52.10±9.41 years. According to patients' perception, the most frequent reasons for joint symptoms were psychological stress/mood disorder (86.1%), followed by infection (49.6%) and trauma (46.4%). The most frequent factors for remission of symptoms were antibiotic use (42.7%), cold weather (34.3%), and hot weather (19%).
CONCLUSION: Psychological stress and mood status are independent factors for relapse periods in patients with RA. These should be considered particularly in patients who are resistant to different treatment regimens and in whom any other reason for disease flare is not obvious.

Entities:  

Keywords:  Depression; anxiety; disease flare; rheumatoid arthritis

Year:  2017        PMID: 28638686      PMCID: PMC5473448          DOI: 10.5152/eurjrheum.2017.16100

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN: 2147-9720


  29 in total

Review 1.  Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis.

Authors:  Ernest Choy
Journal:  Rheumatology (Oxford)       Date:  2012-07       Impact factor: 7.580

2.  Worldwide research productivity in the field of rheumatology from 1996 to 2010: a bibliometric analysis.

Authors:  Tao Cheng; Guoyou Zhang
Journal:  Rheumatology (Oxford)       Date:  2013-03-15       Impact factor: 7.580

3.  Early rheumatoid arthritis in Latin America: low socioeconomic status related to high disease activity at baseline.

Authors:  Loreto Massardo; Bernardo A Pons-Estel; Daniel Wojdyla; Mario H Cardiel; Claudio M Galarza-Maldonado; Mónica P Sacnun; Enrique R Soriano; Ieda M Laurindo; Eduardo M Acevedo-Vásquez; Carlo V Caballero-Uribe; Oslando Padilla; Zoila M Guibert-Toledano; Licia M da Mota; Rubén A Montufar; Leticia Lino-Pérez; José F Díaz-Coto; Angel F Achurra-Castillo; Jaime A Hernández; María H Esteva-Spinetti; Luis A Ramírez; Carlos Pineda; Daniel E Furst
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-08       Impact factor: 4.794

4.  Socioeconomic disparities in pain: the role of economic hardship and daily financial worry.

Authors:  Rebeca Rios; Alex J Zautra
Journal:  Health Psychol       Date:  2011-01       Impact factor: 4.267

5.  Depression and smoking in the U.S. household population aged 20 and over, 2005-2008.

Authors:  Laura A Pratt; Debra J Brody
Journal:  NCHS Data Brief       Date:  2010-04

6.  Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis.

Authors:  Dennis C Ang; Hyon Choi; Kurt Kroenke; Frederick Wolfe
Journal:  J Rheumatol       Date:  2005-06       Impact factor: 4.666

7.  Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

Authors:  M Maes; E Bosmans; R De Jongh; G Kenis; E Vandoolaeghe; H Neels
Journal:  Cytokine       Date:  1997-11       Impact factor: 3.861

8.  Predicting depression in rheumatoid arthritis: the signal importance of pain extent and fatigue, and comorbidity.

Authors:  Frederick Wolfe; Kaleb Michaud
Journal:  Arthritis Rheum       Date:  2009-05-15

9.  A biopsychosocial model of pain and depression in rheumatoid arthritis: a 12-month longitudinal study.

Authors:  T Covic; B Adamson; D Spencer; G Howe
Journal:  Rheumatology (Oxford)       Date:  2003-06-16       Impact factor: 7.580

Review 10.  The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Faith Matcham; Lauren Rayner; Sophia Steer; Matthew Hotopf
Journal:  Rheumatology (Oxford)       Date:  2013-09-03       Impact factor: 7.580

View more
  11 in total

1.  Role of amygdala in stress-induced upregulation of airway IL-1 signaling in asthma.

Authors:  Melissa A Rosenkranz; Stephane Esnault; Lauren Gresham; Richard J Davidson; Bradley T Christian; Nizar N Jarjour; William W Busse
Journal:  Biol Psychol       Date:  2021-11-17       Impact factor: 3.111

Review 2.  Why remission is not enough: underlying disease mechanisms in RA that prevent cure.

Authors:  Georg Schett; Yoshiya Tanaka; John D Isaacs
Journal:  Nat Rev Rheumatol       Date:  2020-12-10       Impact factor: 20.543

3.  Depression and the risk of rheumatoid arthritis.

Authors:  Isabelle A Vallerand; Scott B Patten; Cheryl Barnabe
Journal:  Curr Opin Rheumatol       Date:  2019-05       Impact factor: 5.006

4.  Antibiotic treatment and flares of rheumatoid arthritis: a self-controlled case series study analysis using CPRD GOLD.

Authors:  Navraj S Nagra; Danielle E Robinson; Ian Douglas; Antonella Delmestri; Stephanie G Dakin; Sarah J B Snelling; Andrew J Carr; Daniel Prieto-Alhambra
Journal:  Sci Rep       Date:  2019-06-20       Impact factor: 4.379

Review 5.  The Link Between Autonomic Nervous System and Rheumatoid Arthritis: From Bench to Bedside.

Authors:  Francesca Ingegnoli; Massimiliano Buoli; Flavia Antonucci; Lavinia Agra Coletto; Cecilia Maria Esposito; Roberto Caporali
Journal:  Front Med (Lausanne)       Date:  2020-12-07

6.  Physical and Emotional Burden of Rheumatoid Arthritis in Saudi Arabia: An Exploratory Cross-Sectional Study.

Authors:  Mohammed A Omair; Alper Erdogan; Nicole Tietz; Rieke Alten
Journal:  Open Access Rheumatol       Date:  2020-12-24

7.  Mental health, fatigue and function are associated with increased risk of disease flare following TNF inhibitor tapering in patients with rheumatoid arthritis: an exploratory analysis of data from the Optimizing TNF Tapering in RA (OPTTIRA) trial.

Authors:  Katie Bechman; Fang En Sin; Fowzia Ibrahim; Sam Norton; Faith Matcham; David Lloyd Scott; Andrew Cope; James Galloway
Journal:  RMD Open       Date:  2018-05-17

8.  Introduction and switching of biologic agents are associated with antidepressant and anxiolytic medication use: data on 42 815 real-world patients with inflammatory rheumatic disease.

Authors:  Vasiliki-Kalliopi Bournia; Maria G Tektonidou; Dimitrios Vassilopoulos; Katerina Laskari; Stylianos Panopoulos; Kalliopi Fragiadaki; Konstantinos Mathioudakis; Anastasios Tsolakidis; Panagiota Mitrou; Petros P Sfikakis
Journal:  RMD Open       Date:  2020-09

9.  Mental distress among adult patients with eosinophilic esophagitis.

Authors:  Willemijn E de Rooij; Floor Bennebroek Evertsz'; A Lei; Albert J Bredenoord
Journal:  Neurogastroenterol Motil       Date:  2020-12-31       Impact factor: 3.598

10.  Sleep Disturbances are a Significant Predictor of Chikungunya Arthritis Flare Severity.

Authors:  Sarah R Tritsch; Richard Amdur; Liliana Encinales; Andres Cadena; Paige Fierbaugh; Geraldine Avendaño; Carlos Andres Herrera Gomez; Karol Suchowiecki; Evelyn Mendoza-Torres; Wendy Rosales; Dennys Jimenez; Carlos Alberto Perez Hernandez; Alfonso Sucerquia Hernandez; Paula Bruges Silvera; Yerlenis Galvis Crespo; Alberto David Cabana Jimenez; Jennifer Carolina Martinez Zapata; Christopher N Mores; Gary S Firestein; Gary Simon; Aileen Y Chang
Journal:  J Cell Immunol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.